| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 8.164 | 11.043 | 3.068 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 8.170 | 11.060 | 3.069 | 0 | 0 | 0 | 0 | 0 | 0 | 174 |
| Total Expenses - EUR | 13.291 | 11.646 | 3.042 | 2.612 | 721 | 0 | 0 | 0 | 27 | 1.802 |
| Gross Profit/Loss - EUR | -5.121 | -586 | 27 | -2.612 | -721 | 0 | 0 | 0 | -27 | -1.628 |
| Net Profit/Loss - EUR | -5.600 | -586 | -15 | -2.612 | -721 | 0 | 0 | 0 | -27 | -1.628 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Advanced Medical Research S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 3.096 | 2.180 | 1.925 | 1.890 | 1.853 | 1.818 | 1.778 | 1.783 | 1.778 | 0 |
| Current Assets | 309 | 4.188 | 2.931 | 2.024 | 437 | 429 | 419 | 421 | 268 | 262 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 235 | 170 | 2.898 | 1.985 | 162 | 159 | 156 | 156 | 5 | 0 |
| Cash | 74 | 4.018 | 33 | 40 | 274 | 269 | 263 | 264 | 263 | 262 |
| Shareholders Funds | 586 | -6 | -21 | -2.632 | -3.303 | -3.240 | -3.169 | -3.178 | -3.196 | -4.806 |
| Social Capital | 67 | 67 | 66 | 64 | 63 | 62 | 61 | 61 | 61 | 60 |
| Debts | 2.818 | 6.374 | 4.877 | 6.547 | 5.593 | 5.487 | 5.366 | 5.382 | 5.242 | 5.068 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7211 - 7211" | |||||||||
| CAEN Financial Year |
7211
|
|||||||||
Comments - Advanced Medical Research S.r.l.